# FDA Inspection 833195 - Biomat USA Inc - May 22, 2013

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/41c1ba68-24eb-4e2b-afd6-a16b63004cd7
Source feed: FDA_Inspections

> FDA Inspection 833195 for Biomat USA Inc on May 22, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 833195
- Company Name: Biomat USA Inc
- Inspection Date: 2013-05-22
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1116504 - 2020-01-15](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/adda2d7b-61d4-4c43-b8b0-d1458f2c3c4e)
- [FDA Inspection 1009236 - 2017-04-07](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/127f3f1c-6c07-4705-ab6d-e94cb14eb347)
- [FDA Inspection 923750 - 2015-04-27](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/f09529b5-39d7-431f-8e0b-6ccfa7881d1a)
- [FDA Inspection 718878 - 2011-04-08](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/c9689567-5e01-4c20-bf65-d3b87c1eb9b8)

Company: https://www.keypedia.com/companies/biomat-usa-inc/c8895e62-b4f9-473c-b69e-d348867d764e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d